Neonatal Neurological Observation With Video AI
Run by Artemis AI Labs · NCT07628829 · Data updated 2026-11-12
This study tests a real-time, non-contact video AI system to help monitor brain health in newborns with suspected brain injury during their hospital stay.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Artemis AI Labs Industry-sponsored |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Status | Recruiting |
| Started | July 13, 2026 |
| Main results expected | July 12, 2027 |
| Study ends | July 12, 2029 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07628829 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infants admitted to newborn services (including NICU) at participating hospitals, with parent or legal representative consent.
✕Probably not a fit
Neonates for whom the AI monitoring provides no additional clinical information beyond standard care or who do not exhibit measurable movement changes relevant to the assessed outcomes.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
NeoNOVA is a multi-site, prospective, single-arm observational study evaluating NeoPose, a low-cost AI video tool that tracks infant movements and landmarks via continuous bedside video. The study compares AI-derived measurements to human-labeled video and standard clinical exams to see how accurately movement and landmarks are identified. It also examines whether a movement index derived from the video correlates with established neurological assessments such as N-PASS and modified Sarnat scores. Data are collected passively from enrollment to discharge using a bedside monitoring system. The goal is to determine feasibility and potential clinical value of continuous 영상-based neuromonitoring in neonates with encephalopathy or sedation concerns.
Why it matters
Potential benefit: If successful, the approach could enable continuous, non-invasive monitoring to support earlier detection of neurologic changes in newborns.
How similar studies have gone: Previous work in neonatal video analysis has shown promise in automating movement assessment, but large-scale clinical validation remains limited, making this approach relatively novel but building on prior signals.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed and dated informed consent from at least one parent or legally authorized representative (LAR) who is at least 18 years old. * Parent/LAR expresses willingness to comply with study procedures for the duration of the infant's hospital stay. * Infant of any sex (including intersex/undetermined) admitted to newborn services (including the NICU) at a participating hospital. Exclusion Criteria: * Parents or LAR unable to provide informed consent or are under the age of 18. * Non-viable neonates
Where it's running
-
Mount Sinai Hospital
New York, New York, United States Recruiting -
Weill Cornell Medicine / NewYork-Presbyterian Hospital
New York, New York, United States Not yet recruiting
Study contacts
- Principal investigator: Benjamin Glicksberg, PhD — Icahn School of Medicine at Mount Sinai
- Study coordinator: Saum Naderi, MA
- Email: saum@artemisailabs.com
- Phone: 714-913-3641
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating eye function in babies with brain injury
This study is trying to see how eye function in babies with brain injuries affects their development over time.
-
Testing Levetiracetam for treating neonatal seizures
This study is testing how much of the medication Levetiracetam is safe to give to newborns with seizures to see if it works better than the standard treatment.
-
Evaluating Sovateltide for treating brain injury in newborns
This study is testing a new treatment called Sovateltide to see if it can help newborns with brain injuries caused by lack of oxygen during birth.
-
Newborn Brain Wave Checker: See if CergenX Wave matches the Sarnat exam
This study tests whether the CergenX Wave software, which analyzes a newborn's EEG via a small four-electrode setup, can match the standard Sarnat examination in babies with suspected neonatal encephalopathy.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Perioperative risks in adults with Brugada syndrome during anesthesia and related procedures
This registry follows adults with Brugada syndrome to see how often dangerous heart rhythms occur around anesthesia and up to 30 days after.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.